Innovation 

Biotech Business Indicators provides a quarterly updated ready reference to biotechnology industry and market developments, using key industry and market statistics.

Contact list for managers in the Innovation Division

This report outlines the results of a survey of n=105 businesses commissioned by NanoVic and the Australian Government Department of Industry, Tourism and Resources (DITR) to establish current investment in and attitudes towards nanotechnology and to identify potential barriers to investing in the emerging science. The survey sample was drawn from the manufacturing, materials, automotive, ICT/ electronics, textiles, and biotechnology industries.

A study of the impact of the Australian Government's R&D tax Concession on 116 firms that are current or past participants in the program.

A 2007 survey to gauge community understanding of nanotechnology.

A 2006 Nanotechnology business survey report to gauge the level of awareness and understanding of nanotechnology issues among targeted firms with a potential interest in nanotechnology.

A comparison of Intellectual Property protection activity in Australia, the USA, and the EU

Information on the Innovation Investment Fund

Information on the Pre-Seed fund

This is the options report for a National Nanotechnology Strategy prepared by the National Nanotechnology Strategy Taskforce. June 2006.

This is the Executive Summary for the Options for a National Nanotechnology Strategy Report.

Summary of nanotechnology related surveys undertaken by or for the Department since October 2004

Biotech Business Indicators provides a quarterly updated ready reference to biotechnology industry and market developments, using key industry and market statistics.

In addition to the $1 billion over five years announced in 2004 for Commercial Ready, the Australian Government has allocated $90.3 million over ten years to Commercial Ready Plus for emerging companies and spin offs from public research organisations.

A report of a study undertaken to assess the role of and benefits created by intermediaries in the Australian innovation system.

The DITR "Innovation in Manufacturing 2003" paper presents an analysis of innovation in Australian manufacturing in 2001-2003 using micro-level data from the ABS's 2003 Innovation Survey.

This paper, released in April 2006, builds on previous innovation analysis by the Department and the ABS. It presents the results of an econometric investigation into innovation novelty, collaboration and related characteristics in Australian business.

A preliminary study into the Australian Complementary Medicines Industry

Report on the level of IP protection used by SMEs in Australia, undertaken by the Intellectual Property Research Institute of Australia

A summary report on early stage venture capital investments in Australia.

A survey investigating behavioural additionality effects of the R&D Tax Concession program.

Biotech Business Indicators provides a ready reference to biotechnology industry and market developments, using key industry and market statistics.

The following report was prepared for the Department of Industry, Tourism and Resources by Professor Ron Johnston, Executive Director of the Centre for Innovation (ACIIC). It outlines the key issues, drivers and uncertainties for the future of the Australian medical devices industry, and provide major initiatives that the industry can take to grow and remain internationally competitive to the year 2025.

The Department collaborated with the ABS to produce a detailed, policy relevant analysis of the data collected in the 2003 Innovation Survey.

Recent reports concerning aspects of the R&D Tax Concession

The research study provides an overview of the main patterns of innovation in Australian businesses, the general characteristics of innovators and an analysis of expenditure on innovation.

This report is written to raise awareness in the wider business and investor community about nanotechnology, its applications and opportunites

Part of a series of occasional papers to encourage debate on issues relating to emerging industries and technologies.

Biotech Business Indicators provides a quarterly updated ready reference to biotechnology industry and market developments, using key industry and market statistics.

Information on the ICIP

The previous government's 2006 National Nanotechnology Strategy.

A page to house national nanotechnology strategy implementation plan file.

A survey of business angel investors and networks in Australia

Describes the work of the National Nanotechnology Strategy Taskforce in developing options for a coordinated national nanotechnology strategy.

Links to websites within the Department and to other federal and state and territory government agencies involved in innovation policy.

A summary of the 2005 report on the impact that the Commercialising Emerging Technologies (COMET) program has on participating firms in terms of developing knowledge-based skills and innovation capability.

Innovation seminar run by the Innovation Division, featuring Don Soctt-Kemmis

A study, released in February 2005, of a small number of selected participants in the R&D Start and Biotechnology Innovation Fund programs.

This presentation was given by Craig Pennifold, Head of Innovation Division, Department of Industry, Tourism and Resources at the 5th Annual Biotech Summit in August 2007

The Australian Government's Industrial Biotechnology strategy highlights the benefits that industrial biotechnology can offer Australian industry and highlights strategy initiatives for 2007-08.

The Knowledge Intensive Service Activities (KISA) study, released in February 2005, was an OECD project which focussed on developing an understanding of how firms in different industries use KISA in their innovation processes to develop knowledge based skills and capabilities.

This report, produced in July 2004, looks at the role of business plan competitions in the innovation cycle.

Information about the Prime Minister's Science, Engineering and Innovation Council (PMSEIC) and

The annual ABS survey on Australian Venture Capital and Private Equity

Biotech Business Indicators provides a quarterly updated ready reference to biotechnology industry and market developments, using key industry and market statistics.

A study, published in July 2006, on the sources of investment for COMET companies

Boost your Business with Biotech - Hazardous Waste Management flyer and further information

Biotech Business Indicators provides a ready reference to biotechnology industry and market developments, using key industry and market statistics.

A free public forum to assist members of the public gain a better understanding of nanotechnology and to encourage community dialogue about issues concerning nanotechnology will be held in Sydney on Thursday, 3 April.

One area of great interest is biotechnology. Already biotechnology is having a marked impact on how we live, in producing new medicines, helping solve environmental problems and providing fuel and food for the future.

A free public forum to discuss issues about nanotechnology will be held at Adelaide University on the evening of Thursday, 8 May, providing an opportunity to hear varying expert opinions and ask questions.

Dr Terry Cutler, the head of the Government's independent review of Australia's National Innovation System says he is delighted, but daunted, by the number and variety of submissions made to the Review. (8 May 2008)

A free public forum to discuss issues about nanotechnology will be held at the Old Woolstore Apartment Hotel in Hobart on the evening of Tuesday 3 June, providing an opportunity to hear varying expert opinions and to ask questions about nanotechnology.

A free public forum at the University of Western Australia on Wednesday 18 June will provide an opportunity for people to hear a variety of expert opinions and to ask questions about nanotechnology.

A 2007 survey of six Australian Phase 1 clinical trials units.

Public submission to the Nanotechnology Strategy Taskforce.

Public Submission to the Nanotechnology Strategy Taskforce.

Public submission to the Nanotechnology Strategy Taskforce.

Public Submission to the Nanotechnology Strategy Taskforce.

Public submission to the Nanotechnology Strategy Taskforce.

Public Submission to the Nanotechnology Strategy Taskforce.

Public Submission to the Nanotechnology Strategy Taskforce.

Submission to the Nanotechnology Strategy Taskforce.

Public submission to the Nanotechnology Strategy Taskforce.

Public submission to the Nanotechnology Strategy Taskforce.

Public submission to the Nanotechnology Strategy Taskforce.

Nanotechnology Strategy Development submission by the Centre for Regulatory Studies, Monash University.

Public Submission to the Nanotechnology Strategy Taskforce.

Public Submission to the Nanotechnology Strategy Taskforce.

Public submission to the Nanotechnology Strategy Taskforce.

Nanotechnology Submission by Standards Australia.

Public Submission to Nanotechnology Strategy Taskforce.

Public submission for the Nanotechnology Strategy Taskforce.

Public Submissions to the Nanotechnology Strategy Taskforce.

Public Submission to Nanotechnology Strategy Taskforce.

Public Submission to Nanotechnology Strategy Taskforce.

A study of business' understanding of and attitudes towards nanotechnology.